A new blood test shows potential to detect advanced stages of chronic traumatic encephalopathy (CTE) in the living, according to two recent studies published in the medical journal JAMA.
Scientists researching the connection between football and brain damage have long described diagnosing CTE in the living as the holy grail. To date, the disease, which has been linked to repeated blows to the head from football and other contact sports, has been diagnosable only after death.
One study, published Thursday by researchers at Boston University and Banner Health, was based on a small sample of former American football players who donated blood while alive. After those players died, autopsies of their brains determined they had CTE. The researchers then identified a CTE marker by examining the levels of a specific protein in the blood samples.
Michael Alosco, the co-director of clinical research at Boston University’s CTE Center and co-senior author of the study, called the test a “game changer” in the ability to diagnose the degenerative brain illness in the living.
“I’m cautiously optimistic that we can really understand this finding and move it forward in the next five years or so,” Alosco told ESPN.
However, the Boston University and Banner Health test showed promise only in identifying advanced stages of CTE during life — not in the early stages.
The severity of CTE increases as it progresses. In the early stages, it often tends to be symptom-free, while patients in advanced stages present with symptoms such as memory loss, confusion, depression, irritability, and severe mood swings.
The study released Thursday examined 21 deceased football players: 12 who played professionally, seven who played through college, and two who played only through the high school level.
Autopsies showed that most of the former professional players, along with four college players and one high school player, had advanced-stage CTE. The blood tests showed a higher concentration of the identified protein, confirming the diagnosis.
Five players who had both CTE and Alzheimer’s disease showed the highest levels of the protein in their blood.
“We are still in the discovery phase and it’s a small sample size,” Alosco said in a separate statement. “But if future studies validate these findings, this blood test will allow us to detect CTE with a high level of accuracy and open the doors to clinical trials and treatment.”
In a separate study published in JAMA last Friday, a research group from the Washington University School of Medicine in St. Louis also identified the same blood biomarker. That study was based on 11 cases.
Scientists have been trying for years to detect CTE in the living. In 2017, researchers said they used a brain scan to identify the disease in a former NFL player while he was still alive and attempts to use scans as a diagnostic tool are ongoing.
So far, no tests or treatments specific to CTE have been approved by the U.S. Food and Drug Administration.
While the recent findings are a major milestone, the possibility of a CTE test also raises complicated questions for players at all levels of the game, from pee wee to the pros, and their families. Among the potential issues is whether players, particularly those in the NFL, will want to know if they have the disease while still in the league.
Last summer, ESPN asked more than 30 current and former NFL players about a range of CTE-related topics, including whether they would take a test for CTE if one existed.
“Yeah, I would,” Washington Commanders quarterback Marcus Mariota told ESPN. “I think because, at the end of the day, it gives insight to the rest of the NFL, to college kids, to high school kids of what we’re getting ourselves into. Then yeah, absolutely.”
Said Minnesota Vikings safety Joshua Metellus: “I probably wouldn’t want [the test] while I’m in the league, because I think it’ll change the way I play. But I know there’s a lot of guys who are very curious and would like to know.”
